Connect with us

Business

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 – FDA.gov

The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.

Published

on

post featured image
ADVERTISEMENT

For Immediate Release:
November 21, 2020
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
UPS is making dry ice and supplying portable freezers for vaccine distribution | TheHill – The Hill
post featured image
Jefferson County Health Board approves mask order in 3-2 vote – KTVI Fox 2 St. Louis
post featured image
Travelers continue to fly at MSP Airport despite warnings – Minneapolis Star Tribune